BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 23908126)

  • 1. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association.
    Kubota K; Nakanuma Y; Kondo F; Hachiya H; Miyazaki M; Nagino M; Yamamoto M; Isayama H; Tabata M; Kinoshita H; Kamisawa T; Inui K
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):176-85. PubMed ID: 23908126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
    Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
    J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
    Rocha FG; Lee H; Katabi N; DeMatteo RP; Fong Y; D'Angelica MI; Allen PJ; Klimstra DS; Jarnagin WR
    Hepatology; 2012 Oct; 56(4):1352-60. PubMed ID: 22504729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns.
    Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I
    Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.
    Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Kondo Y; Miyazaki M
    Am J Surg Pathol; 2011 Apr; 35(4):512-21. PubMed ID: 21412069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of a mucin-producing bile duct tumor diagnosed over the course of 6 years.
    Yamada S; Kato Y; Hada M; Kotake M; Oyama K; Hara T
    Clin J Gastroenterol; 2017 Dec; 10(6):530-534. PubMed ID: 28913716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary neoplasms and mucinous cystic neoplasms of the hepatobiliary system: demographic differences between Asian and Western populations, and comparison with pancreatic counterparts.
    Zen Y; Jang KT; Ahn S; Kim DH; Choi DW; Choi SH; Heo JS; Yeh MM
    Histopathology; 2014 Aug; 65(2):164-73. PubMed ID: 24456415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.
    Nakanuma Y; Zen Y; Harada K; Ikeda H; Sato Y; Uehara T; Sasaki M
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):211-22. PubMed ID: 19680592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
    Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
    Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
    AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraductal papillary neoplasms of intrahepatic bile duct: a clinicopathologic study of 25 cases].
    Chang XY; Li J; Ren XY; Zhou WX; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):243-7. PubMed ID: 27033387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
    Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
    J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder.
    Bennett S; Marginean EC; Paquin-Gobeil M; Wasserman J; Weaver J; Mimeault R; Balaa FK; Martel G
    HPB (Oxford); 2015 Sep; 17(9):811-8. PubMed ID: 26278323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of "intraductal papillary neoplasm of the bile duct" and patient outcome after surgical resection.
    Nanashima A; Kinoshita N; Nakanuma Y; Zen Y; Sumida Y; Abo T; Hidaka S; Takeshita H; Yasutake T; Hayashi T; Nagayasu T
    Hepatogastroenterology; 2008; 55(85):1167-73. PubMed ID: 18795651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
    Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
    PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm.
    Nakanuma Y; Kakuda Y; Uesaka K; Miyata T; Yamamoto Y; Fukumura Y; Sato Y; Sasaki M; Harada K; Takase M
    Hum Pathol; 2016 May; 51():103-13. PubMed ID: 27067788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.